Innovative Technical Solutions, Inc. Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) Contracts
Federal Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contract operations by Innovative Technical Solutions, Inc. - NAICS 541712
Contractor Sector Analysis
Innovative Technical Solutions, Inc. is a federal government contractor with $0 in Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) sector contracts across 0 awards. Understanding how federal contractors specialize across industry sectors provides insight into their core competencies and dependence on specific procurement categories.
Overview
Total Contract Value: $0
Contract Count: 0
Average Contract Size: $0
Competition Rate: 0%
Small Business Rate: 0%
Frequently Asked Questions
How many Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contracts does Innovative Technical Solutions, Inc. have?
Innovative Technical Solutions, Inc. has 0 federal Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contracts worth a combined $0.
What is the average Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contract size for Innovative Technical Solutions, Inc.?
The average Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contract size for Innovative Technical Solutions, Inc. is $0.
Which agencies award Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contracts to Innovative Technical Solutions, Inc.?
Agency data is being compiled.
What percentage of Innovative Technical Solutions, Inc.'s Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contracts are competitively awarded?
0% of Innovative Technical Solutions, Inc.'s Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) contracts were competitively awarded.